Wall Street analysts forecast that Collegium Pharmaceutical (COLL) will report quarterly earnings of $1.49 per share in its upcoming release, pointing to a year-over-year increase of 12.9$147.04 million, exhibiting an increase of 1.6% compared to the year-ago quarter. Over the last 30 days, there has been a downward revision of 0.2% in the consensus EPS estimate for the quarter, leading to its current level. This signifies the covering analysts' collective r ...